Thousand Oaks, CA, United States of America

Wenyan Shen

This inventor holds 47 USPTO granted patents and 22 published patent applications, plus 2 CIPO patents and 16 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Amgen Inc., Ngm Biopharmaceuticals, Inc., Medarex Inc.. Active years: 2009-2025.

USPTO Granted Patents = 47 (Patent Applications = 22)

% Patents Active = 93.6

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 16 (Patent Applications = 9)

Average Co-Inventor Count = 4.6

ph-index = 13

Forward Citations = 760(Granted Patents)

Location History:

Wayne, PA (US) (2011 - 2014)
Thousand Oaks, CA (US) (2009 - 2018)
Palo Alto, CA (US) (2011 - 2018)
Redwood City, CA (US) (2015 - 2023)

Company Filing History:

Ngm Biopharmaceuticals, Inc.

E. R. Squibb Sons, Inc.

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

Binding Proteins

Beta Klotho

Glucagon Receptor

PCSK9

Metabolic Disorders

Nucleic Acid

Cholesterol Acyltransferase

Dkk-1

Antigen Binding

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12378312 - Polynucleotides encoding human beta klotho antibodies or binding fragments thereof and methods of use thereof (2025-08-05),

2. 12180289 - Binding proteins and methods of use thereof (2024-12-31),

3. 12173060 - Compositions and methods of use for treating metabolic disorders (2024-12-24),

4. 11732049 - Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptor (2023-08-22),

5. 11667708 - Anti-human beta klotho antibody or binding fragment thereof and methods of their use (2023-06-06),

6. 11596676 - Methods of treating nonalcoholic steatohepatitis comprising administering an anti-human beta klotho antibody or binding fragment thereof (2023-03-07),

7. 11530260 - Compositions and methods of use for treating metabolic disorders (2022-12-20),

8. 10995145 - Antibodies which bind human glucagon receptor (2021-05-04),

9. 10975154 - Binding proteins and methods of use thereof (2021-04-13),

10. 10800843 - Beta klotho-binding proteins (2020-10-13),

11. 10744191 - Beta klotho-binding proteins and methods of use thereof (2020-08-18),

12. 10562965 - Compositions and methods of use for treating metabolic disorders (2020-02-18),

13. 10174119 - Binding proteins and methods of use thereof (2019-01-08),

14. 10093735 - Beta-klotho binding proteins (2018-10-09),

15. 10072090 - Human anti-B7RP1 neutralizing antibodies (2018-09-11),

Title: The Innovative Journey of Wenyan Shen

Introduction: Wenyan Shen, a talented inventor hailing from Thousand Oaks, CA, has made significant contributions to the world of technology and innovation.

Latest Patents: Shen's latest patents include groundbreaking inventions in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Shen has worked with renowned tech companies and research institutions, leading teams to develop cutting-edge solutions that have revolutionized various industries. His keen eye for detail and passion for innovation have earned him a reputation as a visionary in the field.

Collaborations: Throughout his career, Shen has collaborated with top scientists, engineers, and researchers from around the globe, fostering a culture of creativity and excellence. His ability to work seamlessly in multidisciplinary teams has led to the successful implementation of numerous projects that have pushed the boundaries of what is possible.

Conclusion: In conclusion, Wenyan Shen's relentless pursuit of innovation and his unwavering commitment to excellence continue to inspire the next generation of inventors and entrepreneurs. His impact on the world of technology is truly remarkable, and his legacy is sure to endure for years to come.